Títol projecte: Assaig clínic fase II sobre l’ús d’un CART humanitzat dirigit contra BCMA (ARI0002h) en pacients amb mieloma múltiple …
BCMA and SLAMF7 chimeric antigen receptors T-cells immunotherapy in multiple myeloma
Títol projecte: BCMA and SLAMF7 chimeric antigen receptors T-cells immunotherapy in multiple myeloma (BITRECS) Agència finançadora: Unió Europea Data inici …
Future prospects of chimeric antigen receptor T-cell therapy for multiple mieloma
(1/4) De Larrea, C.F.; Landgren, O.; Mailankody, S.; Smith, E.2019. Future prospects of chimeric antigen receptor T-cell therapy for multiple …
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
Smith, EL.; Harrington, K.; Staehr, M.; et al; Brentjens, RJ.; (14/26) de Larrea, C.F.2019. GPRC5D is a target for the …
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple mieloma
Jiménez- Segura, R.; Granell, M.; Gironella, M.; et al; Rosiñol, L.; (12/17) de Larrea, C.F.2019. Pomalidomide-Dexamethasone for treatment of soft …
Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis
Gutiérrez- García, G.; Cibeira, M.T.; Rovira, M.; et al; Bladé, J.; (4/22) de Larrea, C.F.2019. Improving security of autologous hematopoietic …
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression
Carlos Fernández de Larrea, Ignacio Isola, Arturo Pereira, Ma Teresa Cibeira, Laura Magnano, Natalia Tovar, Luis-Gerardo Rodríguez-Lobato, Xavier Calvo, Juan I. Aróstegui, Tania Díaz, Ester Lozano, María …